Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.46 |
| ▸ | KDM4A | O75164 | 1/20 | 0.46 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.45 |
| ▸ | FABP3 | P05413 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL5277730 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL10406238 | 0.95 | CA1 (0.67) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL2678684 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL9172170 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL11656700 | 0.95 | CA1 (0.67) | CA1NFKB1KDM4CKDM4APHF8 | |
| Potassium Ion SCHEMBL25191979 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| Zinc Ion SCHEMBL3364891 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL2195531 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL20894203 | 0.95 | CA1 (0.62) | CA1NFKB1KDM4CKDM4APHF8 | |
| SCHEMBL10815605 | 0.95 | CA1 (0.67) | CA1NFKB1KDM4CKDM4APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12138340-B2 | Composition comprising pigment coated with isopropyl titanium triisostearate | L'OREAL (FR) | 2024-11-12 | — | — | US | claimed |
| CN-116327619-B | Moisturizing lipstick and preparation method thereof | 娇时日化（杭州）股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-115224352-A | Dry-method prepared hydrophobic solid electrolyte and preparation method and application thereof | 南木纳米科技(北京)有限公司 | 2022-10-21 | — | — | CN | claimed |
| US-12605324-B2 | Composition comprising ingredients for DIC-gel and polyol | L'OREAL (FR) | 2026-04-21 | — | — | US | disclosed |
| US-12599623-B2 | Skin compositions and methods of use thereof | SHISEIDO COMPANY, LIMITED (JP) | 2026-04-14 | — | — | US | disclosed |
| US-20260090970-A1 | POLYTERPENE FILM FORMER FOR COSMETIC APPLICATIONS | MOMENTIVE PERFORMANCE MAT INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12582597-B2 | Wax of natural origin for cosmetic products | Roelmi HPC s.r.l. (IT) | 2026-03-24 | — | — | US | disclosed |
| US-12514808-B2 | Use of compositions comprising destructurized starch in a complexed form as abrasives and/or structuring agents | NOVAMONT S.P.A. (IT) | 2026-01-06 | — | — | US | disclosed |
| US-20260002090-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP INVESTMENTS LLC (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4661971-A1 | COSMETIC COMPOSITION COMPRISING HYDROPHOBIC AND HYDROPHILIC TREATED PIGMENTS | Chanel Parfums Beauté (FR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250354008-A1 | BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF | MOMENTIVE PERFORMANCE MAT INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-20220218586-A1 | USE OF COMPOSITIONS COMPRISING DESTRUCTURIZED STARCH IN A COMPLEXED FORM AS ABRASIVES AND/OR STRUCTURING AGENTS | NOVAMONT S.P.A. (IT) | 2022-07-14 | — | — | US | disclosed |
| US-20220202669-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | L/OREAL (FR) | 2022-06-30 | — | — | US | disclosed |
| CN-114522112-A | Instant brightening physical concealer long-acting composition, cream and preparation method | 广州市瑞芬化妆品有限公司 | 2022-05-24 | — | — | CN | disclosed |
| US-20220151894-A1 | LIPOPHILIC COSMETIC COMPOSITIONS CONTAINING PELARGONIC ACID ESTERS | NOVAMONT S.P.A. (IT) | 2022-05-19 | — | — | US | disclosed |
| CN-112940188-B | Anti-bending rubber material for data line and preparation method thereof | 深圳市台钜电工有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-20220062327-A1 | SKIN COMPOSITIONS AND METHODS OF USE THEREOF | SHISEIDO COMPANY, LIMITED (JP) | 2022-03-03 | — | — | US | disclosed |
| US-20180296455-A1 | SUNSCREEN COMPOSITION | JOHNSON & JOHNSON CONSUMER INC (US) | 2018-10-18 | — | — | US | disclosed |
| US-20160303020-A1 | SUNSCREEN COMPOSITION | JOHNSON & JOHNSON CONSUMER INC. | 2016-10-20 | — | — | US | disclosed |
| WO-2010085753-A1 | ROSACEA TREATMENTS AND KITS FOR PERFORMING THEM | JR CHEM, LLC (US) | 2010-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605324-B2 | Composition comprising ingredients for DIC-gel and polyol | ALG1, DAD1, DDOST | CA1 211/4885NFKB1 3388/4885KDM4C 2453/4885 |
| US-12138340-B2 | Composition comprising pigment coated with isopropyl titanium triisostearate | TYR, MITF, TTPA | CA1 3620/4885NFKB1 1117/4885KDM4C 4840/4885 |
| US-20220062327-A1 | SKIN COMPOSITIONS AND METHODS OF USE THEREOF | CUTA, TYR, PLOD3 | CA1 3076/4885NFKB1 4040/4885KDM4C 1057/4885 |
| US-12582597-B2 | Wax of natural origin for cosmetic products | CUTA, HACL2, AUP1 | CA1 1291/4885NFKB1 2804/4885KDM4C 2013/4885 |
| US-12599623-B2 | Skin compositions and methods of use thereof | CUTA, COL1A1, COL2A1 | CA1 1412/4885NFKB1 3940/4885KDM4C 323/4885 |
| US-20160303020-A1 | SUNSCREEN COMPOSITION | ERCC5, ERCC1, ERCC4 | CA1 3969/4885NFKB1 1189/4885KDM4C 2074/4885 |
| US-20260090970-A1 | POLYTERPENE FILM FORMER FOR COSMETIC APPLICATIONS | CUTA, LIPE, TNK1 | CA1 4877/4885NFKB1 1194/4885KDM4C 4274/4885 |
| US-20180296455-A1 | SUNSCREEN COMPOSITION | ERCC5, ERCC1, ERCC4 | CA1 3969/4885NFKB1 1189/4885KDM4C 2074/4885 |
| US-20260002090-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | CUTA, KRT18, HACD3 | CA1 3426/4885NFKB1 3914/4885KDM4C 4425/4885 |
| US-20220202669-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | CUTA, DSG1, TYR | CA1 4517/4885NFKB1 1127/4885KDM4C 847/4885 |
| US-20250354008-A1 | BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF | ALG1, PARG, RECQL | CA1 4805/4885NFKB1 3749/4885KDM4C 2539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.